Resection of hepatic metastases from colorectal cancer

ArticleinArchives of Surgery 119(6):647-51 · July 1984with2 Reads
Source: PubMed
We studied 141 patients who had resection of hepatic metastases from colorectal cancer, considering all such lesions removed between 1948 and 1982. The study involved extended observations of patients described previously. Also included were 21 patients who had wedge resections of small metastases done since 1976, who, therefore, did not qualify for analysis of major hepatic resections reported recently (1980 and 1983). The overall five-year survival rate was 25%, significantly higher than that of a group of historical controls who had resectable metastases that were not removed. The size and nature of our extended sample allowed identification of some determinants of favorable prognosis: Dukes' stage of the primary lesion, absence of extrahepatic metastases, and being female. Contrary to our earlier observations, this study justified removal of some multiple hepatic metastases.
    • "We found that significant risk factors for recurrence in patients with CRLM who underwent liver resection included centrally located metastasis, primary tumor located in the transverse colon, metastasis in regional lymph nodes, primary extrahepatic metastasis, synchronous metastasis, multiple and poorly differentiated metastatic lesions, and hepatectomy with resection margin <10 mm. These factors might differ from those described in other studies because of differences in patient populations and inclusion criteria [30,31,333435363738. Adequacy of margins of resection has been shown to be an important and significant prognostic factor in hepatectomy ; a clear margin >1 cm offered the best surgical out- come18192037]; however, even a surgical margin of <1 cm should be considered in patients with CRLM if a 1-cm margin is impossible because of the size or location of the metastasis [22,26]. "
    [Show abstract] [Hide abstract] ABSTRACT: Hepatic metastasectomy for patients with primary colorectal cancer offers better long-term outcome, and chemotherapy can increase the rate of hepatic resectability for patients with initially inoperable disease. The pattern of liver metastasis and status of the primary tumor are rarely discussed in the analysis of long-term outcome. In this report, we evaluate the influence of the pattern of metastasis on clinical features and prognosis. One hundred and fifty-nine patients who underwent hepatic metastasectomy with curative intent for liver metastasis of colorectal cancer between October 1991 and December 2006 were enrolled. Patients were grouped according to whether liver metastasis was centrally or peripherally located, based on imaging and operative findings. Patient demographics, characteristics of the primary and metastatic tumors, and surgical outcomes were analyzed for long-term survival. A greater proportion of patients with centrally located metastases were male, as compared with those with peripherally located metastases. Compared with patients with peripherally located metastases, patients with centrally located metastases were more likely to have multiple lesions (P = 0.016), involvement of multiple segments (P = 0.006), large metastases (P < 0.001), and bilobar distribution of metastases (P < 0.001). The estimated 5-year recurrence-free and overall survival rates were 22.4% and 34.2%, respectively. Univariate analysis revealed that centrally located metastasis, primary tumor in the transverse colon, metastasis in regional lymph nodes, initial extrahepatic metastasis, synchronous liver metastasis, multiple lesions, poorly differentiated tumor, and resection margin <10 mm were significant poor prognostic factors for recurrence-free survival and overall survival. Cox regression analysis showed that inadequate resection margin and centrally located liver metastasis were significant predictors of shorter overall survival. In colorectal cancer, centrally located liver metastasis represents a poor prognostic factor after hepatectomy, and is associated with early recurrence. Neoadjuvant chemotherapy may be used to downstage centrally located liver metastases to improve outcome.
    Full-text · Article · Dec 2015
    • "In particular, surgical treatment of metastatic CR cancer has improved long-term outcome. A 5-year survival rate was 25 % in the 80s, progressively increased up to 47 % in 2008 [7,45464748495051. In contrast, the treatment of NCNNNS liver metastases does not have a clearly defined role, mostly because of discrepant characteristics of patients, difficulty in their selection, and lack of high volume series. "
    [Show abstract] [Hide abstract] ABSTRACT: Hepatic resection of liver metastases of non-colorectal, non-neuroendocrine, and non-sarcoma (NCNNNS) primary malignancies seems to improve survival in selected patients. The aims of the current review were to describe long-term results of surgery and to evaluate prognostic factors for survival in patients who underwent resection of NCNNNS liver metastases. We identified 30 full texts (25 single-center and 5 multicenter studies) published after year 1995 and published in English with a total of 3849 patients. For NCNNNS liver metastases, 83.4 % of these subjects were resected. No prior systematic reviews or meta-analyses on this topic were identified. All studies were case series without matching control groups. The most common primary sites were breast (23.8 %), genito-urinary (21.8 %), and gastrointestinal tract (19.8 %). The median 5- and 10-year overall survival were 32.3 % (range 19-42 %) and 24 % (indicated only in two studies, range 23-25 %), respectively, with 71 % of R0 resections. There is evidence suggesting that surgery of NCNNNS metastases is safe, feasible, and effective if treatment is part of a multidisciplinary approach and if indication is based on the prognostic factors underlined in literature analysis.
    Full-text · Article · May 2015
    • "The natural history of CRC had been studied and reported with no survival in 5 years survivors for CRLM whose did not underwent complete resection [13,14]. Based on patients who underwent surgical treatment, clinical risk scores estimating the risk of recurrence and prognosis in patients with CRLM have been published [15,16]. "
    Full-text · Article · Jan 2014 · World Journal of Surgical Oncology
Show more